Home
Conditions
Leukodystrophy, Metachromatic

Clinical trial condition

Leukodystrophy, Metachromatic

Explore clinical trials studying Leukodystrophy, Metachromatic. Study availability and eligibility vary by location and protocol.

34 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Leukodystrophy, Metachromatic trial results

Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations: Children's Hospital Colorado Denver, Colorado, United States

New York Medical College Valhalla, New York, United States

University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

NCT03406962

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +26 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

NCT00418561

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Rigshospitalet Hvidovre, Denmark

View Trial Details

Completed

Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

NCT01510028

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: The Children's Hospital at Westmead Westmead, Australia

Rigshospitalet Copenhagen, Denmark

Hopital de Bicetre Le Kremlin-Bicêtre, Île-de-France Region, France

Center for Pediatric Clinical Studies Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Completed

Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

NCT00633139

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: PhaseOneTrials A/S Hvidovre, Denmark

View Trial Details

Completed

HSCT for High Risk Inherited Inborn Errors

NCT00383448

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

NCT01043640

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +52 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Stem Cell Transplant for Inborn Errors of Metabolism

NCT00176904

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

NCT01626092

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +50 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

NCT00683189

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Cooper University Hospital Camden, New Jersey, United States

View Trial Details

Leukodystrophy, Metachromatic

Leukodystrophy, Metachromatic trial results

Related conditions